Sunny Optical Technology Gross Profit 2019-2025 | SNPTF

Sunny Optical Technology annual/quarterly gross profit history and growth rate from 2019 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Sunny Optical Technology gross profit for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
  • Sunny Optical Technology gross profit for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
  • Sunny Optical Technology annual gross profit for 2024 was $0.975B, a 50.25% increase from 2023.
  • Sunny Optical Technology annual gross profit for 2023 was $0.649B, a 33.91% decline from 2022.
  • Sunny Optical Technology annual gross profit for 2022 was $0.982B, a 27.47% decline from 2021.
Sunny Optical Technology Annual Gross Profit
(Millions of US $)
2024 $975
2023 $649
2022 $982
2021 $1,353
2020 $1,260
2019 $1,122
2018 $742
2017 $3,323
2016 $2,200
2015 $1,718
Sunny Optical Technology Quarterly Gross Profit
(Millions of US $)
2025-06-30
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $8.485B $5.327B
Sunny Optical Technology Group Co., Limited is engaged in the design, research and development, manufacture and sales of optical and optical-related products. Optical components product includes glass spherical and aspherical lenses, plane products, handset lens sets, vehicle lens sets and other various lens sets. Optoelectronic products includes handset camera modules, three-dimensional optoelectronic products, security cameras and other optoelectronic modules and optical instruments includes microscopes, optical measuring instruments and various high-end optical analytical instrument. Sunny Optical Technology Group Co., Limited is based in Yuyao, the People's Republic of China.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.936B 21.88
EssilorLuxottica (ESLOY) France $142.091B 0.00
Stryker (SYK) United States $140.083B 26.86
Medtronic (MDT) Ireland $127.548B 17.67
Boston Scientific (BSX) United States $110.783B 24.50
Medline (MDLN) United States $58.526B 0.00
Lonza Group Ag (LZAGY) Switzerland $48.093B 0.00
ResMed (RMD) United States $36.791B 24.57
GE HealthCare Technologies (GEHC) United States $36.615B 17.54
Agilent Technologies (A) United States $35.584B 22.55
Koninklijke Philips (PHG) Netherlands $30.091B 17.86
Terumo (TRUMY) Japan $21.610B 25.26
Zimmer Biomet Holdings (ZBH) United States $19.115B 11.76
Insulet (PODD) United States $17.076B 53.00
Smith & Nephew SNATS (SNN) United Kingdom $15.372B 0.00
Baxter (BAX) United States $10.182B 8.72
Bio-Rad Laboratories (BIO) United States $6.921B 25.86
Demant (WILYY) Denmark $6.042B 0.00
Envista Holdings (NVST) United States $4.747B 24.14
Lantheus Holdings (LNTH) United States $4.601B 14.02
BillionToOne (BLLN) United States $4.056B 0.00
ICU Medical (ICUI) United States $3.577B 22.71
Shandong Weigao Medical Polymer (SHWGF) China $3.263B 0.00
Prestige Consumer Healthcare (PBH) United States $3.160B 14.91
Haemonetics (HAE) United States $2.684B 11.74
Neogen (NEOG) United States $2.380B 52.10
Phibro Animal Health (PAHC) United States $2.118B 18.66
Perrigo (PRGO) Ireland $2.001B 5.01
LeMaitre Vascular (LMAT) United States $1.989B 40.03
Curaleaf Holdings (CURLF) Canada $1.642B 0.00
AtriCure (ATRC) United States $1.623B 0.00
QuidelOrtho (QDEL) United States $1.602B 11.12
Kestra Medical Technologies (KMTS) United States $1.571B 0.00
Green Thumb Industries (GTBIF) United States $1.446B 63.36
AdaptHealth (AHCO) United States $1.381B 20.00
Lumexa Imaging Holdings (LMRI) United States $1.358B 0.00
BioLife Solutions (BLFS) United States $1.070B 317.57
Capricor Therapeutics (CAPR) United States $1.026B 0.00
InMode (INMD) Israel $0.906B 9.93
Tilray Brands (TLRY) Canada $0.875B 0.00
Valneva SE (VALN) France $0.868B 0.00
Omeros (OMER) United States $0.829B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.757B 0.00
CeriBell (CBLL) United States $0.733B 0.00
VAREX IMAGING (VREX) United States $0.566B 13.52
Brainsway (BWAY) Israel $0.451B 76.63
Canopy Growth (CGC) Canada $0.436B 0.00
Cerus (CERS) United States $0.430B 0.00
Verano Holdings (VRNO) United States $0.396B 0.00
SNDL (SNDL) Canada $0.386B 0.00
Cresco Labs (CRLBF) United States $0.361B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.328B 0.00
Viemed Healthcare (VMD) United States $0.315B 25.09
Evolus (EOLS) United States $0.279B 0.00
Quanterix (QTRX) United States $0.268B 0.00
TriSalus Life Sciences (TLSI) United States $0.243B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Sanuwave Health (SNWV) United States $0.213B 0.00
Utah Medical Products (UTMD) United States $0.205B 18.42
High Tide (HITI) Canada $0.203B 0.00
Aurora Cannabis (ACB) Canada $0.201B 59.17
OraSure Technologies (OSUR) United States $0.197B 0.00
TerrAscend (TSNDF) Canada $0.182B 0.00
Organigram Global (OGI) Canada $0.174B 0.00
Accendra Health (ACH) United States $0.173B 1.74
Vireo Growth (VREOF) United States $0.170B 0.00
Sanara MedTech (SMTI) United States $0.168B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Apyx Medical (APYX) United States $0.142B 0.00
FitLife Brands (FTLF) United States $0.134B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.129B 0.00
Fonar (FONR) United States $0.115B 16.42
MacroGenics (MGNX) United States $0.108B 0.00
Jushi Holdings (JUSHF) United States $0.100B 0.00
Biote (BTMD) United States $0.097B 4.26
Exagen (XGN) United States $0.074B 0.00
ImmuCell (ICCC) United States $0.060B 25.39
Sharps Technology (STSS) United States $0.051B 0.00
Nephros (NEPH) United States $0.044B 31.54
Cytosorbents (CTSO) United States $0.040B 0.00
Rockwell Medical (RMTI) United States $0.040B 0.00
Veru (VERU) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
United-Guardian (UG) United States $0.030B 15.35
Jin Medical (ZJYL) China $0.022B 0.00
Bonk (BNKK) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
INLIF (INLF) China $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Agape ATP (ATPC) $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00